Abstract
Health-related quality of life (HRQoL) in patients with schizophrenia is related to the severity of psychiatric symptoms. The objective of this study is to analyze whether the symptoms that influence HRQoL are similar in women and men. Data were part of the Pattern study, an international observational investigation which collected data from 1379 outpatients with schizophrenia. Patients were evaluated with the Mini International Neuropsychiatric Inventory, the Clinical Global Impression-Schizophrenia, and the Positive and Negative Syndrome Scale (PANSS), and reported their quality of life using the Schizophrenia Quality of Life Scale (SQLS), the Short Form-36 (SF-36), and the EuroQol-5 Dimension (EQ-5D). Men reported higher HRQoL on all scales. PANSS total score was 80.6 (SD 23.6) for women and 77.9 (SD 22.1) for men. In women, a higher PANSS negative score and a higher PANSS affective score were associated with a lower SQLS score. In men, a higher PANSS positive score and a higher PANSS affective score were associated with a lower SQLS score. The same pattern appeared with EQ-VAS and EQ-5D tariff. In women, greater age and higher PANSS affective score were associated with a lower SF-36 mental component score. In men, higher PANSS affective, positive, and cognitive scores were associated with a lower SF-36 mental component score. This study shows that HRQoL is influenced by different psychiatric symptoms in women and men. This may have significant implications when deciding the main treatment target in patients with schizophrenia.
ClinicalTrials.gov Identifier: https://clinicaltrials.gov/ct2/show/NCT01634542
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alessandrini Lançon C, Fond G, Faget-Agius C, Richieri R, Faugere M, Metairie E, Boucekine M, Llorca PM, Auquier P, Boyer LM (2016) A structural equation modelling approach to explore the determinants of quality of life in schizophrenia. Schizophr Res 171:SP-27–SP-34
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders
Awad AG, Voruganti LNP (2012) Measuring quality of life in patients with schizophrenia: an update. Pharmacoeconomics 30:183–195. https://doi.org/10.2165/11594470
Bardenstein KK, McGlashan TH (1990) Gender differences in affective, schizoaffective, and schizophrenic disorders. A review. Schizophr Res 3:159–172
Becker T, Leese M, Krumm S, Ruggeri M, Vázquez-Barquero JL, EPSILON Study Group (2005) Needs and quality of life among patients with schizophrenia in five European centres: what is the impact of global functioning scores? Soc Psychiatry Psychiatr Epidemiol 40:628–634. https://doi.org/10.1007/s00127-005-0937-7
Bisegger C, Cloetta B, von Rueden U et al (2005) Health-related quality of life: gender differences in childhood and adolescence. Soz Praventivmed 50:281–291. https://doi.org/10.1007/s00038-005-4094-2
Bobes J, A-Portilla PG (2005) Quality of life measures in schizophrenia. Eur Psychiatry 20(Suppl 3):S313–S317. https://doi.org/10.1016/S0924-9338(05)80182-8
Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, Lloyd Jones M, Paisley S, O’Cathain A, Barkham M, Knapp M, Byford S, Gilbody S, Parry G (2014) A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess (Rockv) 18:1–188. https://doi.org/10.3310/hta18340
Browne S, Roe M, Lane A et al (1996) Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 94:118–124. https://doi.org/10.1016/0920-9964(96)85728-8
Caqueo-Urízar A, Fond G, Urzúa A, Boyer L (2018) Gender differences in schizophrenia: a multicentric study from three Latin-America countries. Psychiatry Res 266:65–71. https://doi.org/10.1016/j.psychres.2018.05.032
Carpiniello B, Pinna F, Tusconi M, Zaccheddu E, Fatteri F (2012) Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study. Schizophr Res Treatment 2012:1–8. https://doi.org/10.1155/2012/576369
Cherepanov D, Palta M, Fryback DG, Robert SA (2010) Gender differences in health-related quality-of-life are partly explained by sociodemographic and socioeconomic variation between adult men and women in the US: evidence from four US nationally representative data sets. Qual Life Res 19:1115–1124. https://doi.org/10.1007/s11136-010-9673-x
Cramer JA, Rosenheck R, Xu W et al (2000) Quality of life in schizophrenia: a comparison of instruments. Schizophr Bull 26:659–666. https://doi.org/10.1093/oxfordjournals.schbul.a033484
Dolan P, Gudex C, Kind P, Williams A (1995) A social tariff for EuroQol: results from a UK general population survey. Work, Pap
Eack SM, Newhill CE (2007) Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull 33:1225–1237. https://doi.org/10.1093/schbul/sbl071
Fond G, Boyer L, Leboyer M, Godin O, Llorca PM, Andrianarisoa M, Berna F, Brunel L, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Dubreucq J, Faget C, Gabayet F, Mallet J, Misdrahi D, Rey R, Lancon C, Passerieux C, Roux P, Vidailhet P, Yazbek H, Schürhoff F, Bulzacka E, Andrianarisoa M, Aouizerate B, Berna F, Blanc O, Brunel L, Bulzacka E, Capdevielle D, Chereau-Boudet I, Chesnoy-Servanin G, Danion J, D'Amato T, Deloge A, Delorme C, Denizot H, Dorey JM, Dubertret C, Dubreucq J, Faget C, Fluttaz C, Fond G, Fonteneau S, Gabayet F, Giraud-Baro E, Hardy-Bayle MC, Lacelle D, Lançon C, Laouamri H, Leboyer M, le Gloahec T, le Strat Y, Llorca, Mallet J, Metairie E, Misdrahi D, Offerlin-Meyer I, Passerieux C, Peri P, Pires S, Portalier C, Rey R, Roman C, Sebilleau M, Schandrin A, Schurhoff F, Tessier A, Tronche A, Urbach M, Vaillant F, Vehier A, Vidailhet P, Vilà E, Yazbek H, Zinetti-Bertschy A (2018) Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort. Schizophr Res 195:357–365. https://doi.org/10.1016/j.schres.2017.09.027
Fransen M, Edmonds J (1999) Reliability and validity of the EuroQol in patients with osteoarthritis of the knee. Rheumatol 38:807–813. https://doi.org/10.1093/rheumatology/38.9.807
French CT, Fletcher KE, Irwin RS (2004) Gender differences in health-related quality of life in patients complaining of chronic cough. Chest 125:482–488. https://doi.org/10.1378/chest.125.2.482
Galuppi A, Turola M, Nanni M, Mazzoni P, Grassi L (2010) Schizophrenia and quality of life: how important are symptoms and functioning? Int J Ment Health Syst 4:31. https://doi.org/10.1186/1752-4458-4-31
Gijsberts CM, Agostoni P, Hoefer IE, Asselbergs FW, Pasterkamp G, Nathoe H, Appelman YE, de Kleijn DPV, den Ruijter HM (2015) Gender differences in health-related quality of life in patients undergoing coronary angiography. Open Hear 2:e000231. https://doi.org/10.1136/openhrt-2014-000231
Guajardo VD, Terroni L, Sobreiro MDFM et al (2015) The influence of depressive symptoms on quality of life after stroke: a prospective study. J Stroke Cerebrovasc Dis 24:201–209. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.08.020
Hansson L (2006) Determinants of quality of life in people with severe mental illness. Acta Psychiatr Scand 113:46–50. https://doi.org/10.1111/j.1600-0447.2005.00717.x
Haro JM, Kamath SA, Ochoa S, Novick D, Rele K, Fargas A, Rodriguez MJ, Rele R, Orta J, Kharbeng A, Araya S, Gervin M, Alonso J, Mavreas V, Lavrentzou E, Liontos N, Gregor K, Jones PB, on behalf of the SOHO Study Group* (2003) The clinical global impression-schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl 107:16–23
Haro JM, Altamura C, Corral R, Elkis H, Evans J, Malla A, Krebs MO, Zink M, Bernasconi C, Lalonde J, Nordstroem AL (2015) Understanding the impact of persistent symptoms in schizophrenia: cross-sectional findings from the pattern study. Schizophr Res 169:234–240. https://doi.org/10.1016/j.schres.2015.09.001
Jarema M, Konieczyńska Z (2001) Quality of life in schizophrenia: impact of psychopathology, patients’ gender and antipsychotic treatment. Int J Psychiatry Clin Pract 5:19–26
Jenkinson C, Coulter A, Wright L (1993) Short form 36 (SF 36) health survey questionnaire: normative data for adults of working age. BMJ 306:1437–1440
Jenkinson C, Wright L, Coulter A (1994) Criterion validity and reliability of the SF-36 in a population sample. Qual Life Res 3:7–12. https://doi.org/10.1007/BF00647843
Katschnig H (2000) Schizophrenia and quality of life. Acta Psychiatr Scand Suppl 102:33–37. https://doi.org/10.1034/j.1600-0447.2000.00006.x
Katschnig H (2006) Quality of life in mental disorders: challenges for research and clinical practice. World Psychiatry 5:139–145
Kay SR, Fiszbein AOL (1987) The positive and negative syndrome scale for schizophrenia. Schizophr Bull 13:261–276. https://doi.org/10.1093/schbul/13.2.261
Krysta K, Murawiec S, Klasik A et al (2013) Sex-specific differences in cognitive functioning among schizophrenic patients. Psychiatria Danubina, In
Kumar R, Verma A, Kujur N (2010) Differences in levels of disability and quality of life between genders in schizophrenia remission. Ind Psychiatry J 19:50–54. https://doi.org/10.4103/0972-6748.77638
Kurtz MM (2006) Symptoms versus neurocognitive skills as correlates of everyday functioning in severe mental illness. Expert Rev Neurother 6:47–56
Lecrubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Harnett Sheehan K, Janavs J, Dunbar GC (1997) The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 12:224–231. https://doi.org/10.1016/S0924-9338(97)83296-8
Linde L, Sørensen J, Ostergaard M et al (2008) Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 35:1528–1537
Lindenmayer JP, Grochowski S, Hyman RB (1995) Five factor model of schizophrenia: replication across samples. Schizophr Res 14:229–234. https://doi.org/10.1016/0920-9964(94)00041-6
Lysaker PH, Vohs JL, Tsai J (2009) Negative symptoms and concordant impairments in attention in schizophrenia: associations with social functioning, hope, self-esteem and internalized stigma. Schizophr Res 110:165–172. https://doi.org/10.1016/j.schres.2009.01.015
Mauriño J, Sanjúan J, Haro JM et al (2011) Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia. Patient Prefer Adherence:5. https://doi.org/10.2147/PPA.S24479
Ochoa S, Haro JM, Usall J, Autonell J, Vicens E, Asensio F, NEDES group (2005) Needs and its relation to symptom dimensions in a sample of outpatients with schizophrenia. Schizophr Res 75:129–134. https://doi.org/10.1016/j.schres.2004.06.002
Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J (2012) Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment 2012:1–9. https://doi.org/10.1155/2012/916198
Orfila F, Ferrer M, Lamarca R, Tebe C, Domingo-Salvany A, Alonso J (2006) Gender differences in health-related quality of life among the elderly: the role of objective functional capacity and chronic conditions. Soc Sci Med 63:2367–2380. https://doi.org/10.1016/j.socscimed.2006.06.017
Papaioannou D, Brazier J, Parry G (2011) How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review. Value Health 14:907–920. https://doi.org/10.1016/j.jval.2011.04.006
Perez J, Russo DA, Stochl J, Byford S, Zimbron J, Graffy JP, Painter M, Croudace TJ, Jones PB (2013) Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial. Trials 14:222. https://doi.org/10.1186/1745-6215-14-222
Rabin R, de Charro F (2001) EQ-SD: a measure of health status from the EuroQol group. Ann Med 33:337–343. https://doi.org/10.3109/07853890109002087
Röder-Wanner UU, Priebe S (1998) Objective and subjective quality of life of first-admitted women and men with schizophrenia. Eur Arch Psychiatry Clin Neurosci 248:250–258. https://doi.org/10.1007/s004060050046
Ruggeri M, Nosè M, Bonetto C, Cristofalo D, Lasalvia A, Salvi G, Stefani B, Malchiodi F, Tansella M (2005) Changes and predictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice. Br J Psychiatry 187:121–130. https://doi.org/10.1192/bjp.187.2.121
Schram MT, Baan CA, Pouwer F (2009) Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rev 5:112–119. https://doi.org/10.2174/157339909788166828
Shtasel DL, Gur RE, Gallacher F, Heimberg C, Gur RC (1992) Gender differences in the clinical expression of schizophrenia. Schizophr Res 7:225–231
Siegrist K, Millier A, Amri I, Aballéa S, Toumi M (2015) Association between social contact frequency and negative symptoms, psychosocial functioning and quality of life in patients with schizophrenia. Psychiatry Res 230:860–866. https://doi.org/10.1016/j.psychres.2015.11.039
Thornicroft G, Leese M, Tansella M, Howard L, Toulmin H, Herran A, Schene A (2002) Gender differences in living with schizophrenia. A cross-sectional European multi-site study. Schizophr Res 57:191–200. https://doi.org/10.1016/S0920-9964(01)00318-8
Usall J, Haro JM, Ochoa S, Marquez M, Araya S, the NEDES group* (2002) Influence of gender on social outcome in schizophrenia. Acta Psychiatr Scand 106:337–342. https://doi.org/10.1034/j.1600-0447.2002.01351.x
Ventura J, Tom SR, Jetton C, Kern RS (2013) Memory functioning and negative symptoms as differential predictors of social problem solving skills in schizophrenia. Schizophr Res 143:307–311. https://doi.org/10.1016/j.schres.2012.10.043
Vila-Rodriguez F1, Ochoa S, Autonell J, Usall J, Haro JM (2011) Complex interaction between symptoms, social factors, and gender in social functioning in a community-dwelling sample of schizophrenia.Psychiatr Q 82:261–274. https://doi.org/10.1007/s11126-011-9168-0
Volavka J, Citrome L (2011) Pathways to aggression in schizophrenia affect results of treatment. Schizophr Bull 37:921–929
Ware J, Sherbourne C (1992) The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473–483
Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, Fitzpatrick R, Jenkinson C (2000) Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry 177:42–46. https://doi.org/10.1192/bjp.177.1.42
Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS (2007) Impact of sociodemographic and clinical factors on subjective quality of life in schizophrenia patients in Beijing, China. J Nerv Ment Dis 195:853–856. https://doi.org/10.1097/NMD.0b013e3181568347
Zeng Y, Zhou Y, Lin J, Zhou Y, Yu J (2015) Generic and disease-specific quality of life and its predictors among Chinese inpatients with schizophrenia. Psychiatry Res 228:724–728. https://doi.org/10.1016/j.psychres.2015.05.033
Zhao N, Wang X, Wu W, Hu Y, Niu Y, Wang X, Gao C, Zhang N, Fang Y, Huang J, Liu T, Jia F, Zhu X, Hu J, Wang G (2017) Gender differences in quality of life and functional disability for depression outpatients with or without residual symptoms after acute phase treatment in China. J Affect Disord 219:141–148. https://doi.org/10.1016/j.jad.2017.05.021
Acknowledgements
We want to thank all participating patients, families, and clinicians.
Author information
Authors and Affiliations
Contributions
The statistical analysis and manuscript content were directed, conducted, and approved by the authors.
Corresponding author
Ethics declarations
Ethical approval
The protocol and consent procedures were approved by all local Institutional Review Boards/Ethics Committees before study initiation. All patients and caregivers provided informed consent.
Conflict of interest
CD, JE, RC, and MVM have no conflict of interest. CB is a contractor of F. Hoffmann- La Roche, Ltd. ALN is an employee of F. Hoffmann- La Roche, Ltd. JMH has acted as a consultant, participated in advisory boards or given educational presentations for Eli Lilly and Co., Lundbeck, Otsuka, F. Hoffmann- La Roche Ltd., and Takeda.
Rights and permissions
About this article
Cite this article
Domenech, C., Bernasconi, C., Moneta, M.V. et al. Health-related quality of life associated with different symptoms in women and in men who suffer from schizophrenia. Arch Womens Ment Health 22, 357–365 (2019). https://doi.org/10.1007/s00737-018-0896-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-018-0896-0